These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
398 related articles for article (PubMed ID: 17002052)
1. [Efficiency of chemotherapy of destructive pulmonary tuberculosis, based on the results of rapid detection of drug sensitivity to isoniazid and rifampicin with the "TB-Biochip" test system]. Kuz'min AV; Vasil'eva IA; Chernousova LN Probl Tuberk Bolezn Legk; 2006; (8):17-23. PubMed ID: 17002052 [TBL] [Abstract][Full Text] [Related]
2. [New technologies in the determination of drug susceptibility in Mycobacterium tuberculosis]. Skotnikova OI; Mikhaĭlovich VM; Nosova EIu; Lapa SA; Griadunov DA; Donnikov MIu; Badleeva MV; Galkina KIu; Dorozhkova IR; Litvinov VI; Zasedatelev AS; Moroz AM; Mirzabekov AD Probl Tuberk Bolezn Legk; 2004; (6):40-2. PubMed ID: 15315132 [TBL] [Abstract][Full Text] [Related]
3. [Fast identification of rifampicin-and isoniazid resistance of M. Tuberculosis strains by the "TB-biochip" test system]. Isakova ZhT Georgian Med News; 2008 May; (158):15-9. PubMed ID: 18560033 [TBL] [Abstract][Full Text] [Related]
4. [Determination of multidrug resistance of M. tuberculosis by different methods]. Poliakov AE; Safonova SG; Skotnikova OI Probl Tuberk Bolezn Legk; 2006; (6):40-2. PubMed ID: 16881235 [TBL] [Abstract][Full Text] [Related]
5. [The characteristics of the sensitivity of Mycobacterium tuberculosis to rifampicin and isoniazid through determination of mutations in the genes rpoB, katG, inhA, oxyR, and kasA by different molecular biological assays]. Skotnikova OI; Galkina KIu; Nosova EIu; Krasnova MA; Moroz AM Probl Tuberk Bolezn Legk; 2005; (8):42-5. PubMed ID: 16209020 [TBL] [Abstract][Full Text] [Related]
6. [Clinical value of microchip technology in determination of drug resistance of Mycobacterium tuberculosis]. Vasil'eva IA; Chernousova LN; Zasedatelev AS; Sobolev AIu; Mikhaĭlovich VM Probl Tuberk; 2002; (6):21-4. PubMed ID: 12227044 [TBL] [Abstract][Full Text] [Related]
7. A novel genotypic test for rapid detection of multidrug-resistant Mycobacterium tuberculosis isolates by a multiplex probe array. Zhang SL; Shen JG; Xu PH; Li DX; Sun ZQ; Li L; Yang ZR; Sun Q J Appl Microbiol; 2007 Oct; 103(4):1262-71. PubMed ID: 17897230 [TBL] [Abstract][Full Text] [Related]
8. [Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone]. Belianin II; Shmelev EI Probl Tuberk Bolezn Legk; 2004; (7):32-5. PubMed ID: 15379039 [TBL] [Abstract][Full Text] [Related]
9. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis. Park SK; Kim JH; Kang H; Cho JS; Smego RA Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342 [TBL] [Abstract][Full Text] [Related]
10. Rapid, accurate determination of multidrug resistance in M. tuberculosis isolates and sputum using a biochip system. Guo Y; Zhou Y; Wang C; Zhu L; Wang S; Li Q; Jiang G; Zhao B; Huang H; Yu H; Xing W; Mitchelson K; Cheng J; Zhao Y Int J Tuberc Lung Dis; 2009 Jul; 13(7):914-20. PubMed ID: 19555544 [TBL] [Abstract][Full Text] [Related]
11. [The course of a process and the efficiency of treatment of pulmonary tuberculosis patients excreting Mycobacterium tuberculosis with extensive drug resistance to antituberculous drugs]. Mishin VIu; Komissarova OG; Chukanov VI; Kononets AS Probl Tuberk Bolezn Legk; 2009; (2):50-2. PubMed ID: 19382643 [TBL] [Abstract][Full Text] [Related]
12. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)]. Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898 [TBL] [Abstract][Full Text] [Related]
13. [A role of the biological chip test in the determination of rifampicin resistance in Mycobacteria in adolescents with active pulmonary tuberculosis]. Firsova VA; Poluektova FG; Kuz'min AV; Chernousova LN Probl Tuberk Bolezn Legk; 2004; (8):28-30. PubMed ID: 15478555 [TBL] [Abstract][Full Text] [Related]
14. [Efficacy of chemotherapy for tuberculosis in patients who isolate drug-resistant strains of M. tuberculosis with different genotypes]. Vasil'eva IA; Andreevskaia SN; Smirnova TG; Chernousova LI; Chukanov VI Probl Tuberk Bolezn Legk; 2004; (8):25-8. PubMed ID: 15478554 [TBL] [Abstract][Full Text] [Related]
15. [Effectiveness of treatment with rifampicin and isoniazid in association with ethambutol or prothionamide in patients with recently detected pulmonary tuberculosis]. Homenko AG; Ciukanov VL Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1979; 28(4):211-8. PubMed ID: 232302 [TBL] [Abstract][Full Text] [Related]
16. [Considerations about the efficiency of treatment regimens with fixed Rifampicin-Isoniazid combinations in pulmonary tuberculosis]. Munteanu I; Husar I; Didilescu C; Stoicescu IP Pneumologia; 2004; 53(1):23-5. PubMed ID: 18210717 [TBL] [Abstract][Full Text] [Related]
17. [Use of biological microchips in the determination of drug-resistance of Mycobacterium tuberculosis to rifampicin]. Isakova ZhT; Pak OA; Iusupova EIu; Myrzaliev BB; Chubakov TCh; Goncharova ZA; Tumashova AF; Kozhomkulov MD; Kozhomkulov DK; Alisherov ASh; Friedland J; Aldashev AA Probl Tuberk Bolezn Legk; 2005; (8):50-3. PubMed ID: 16209022 [TBL] [Abstract][Full Text] [Related]
19. [Efficacy of treatment for pulmonary tuberculosis with multidrug mycobacterial resistance]. Mishin VIu; Chukanov VI; Vasil'eva IA Probl Tuberk; 2002; (12):18-23. PubMed ID: 12611329 [TBL] [Abstract][Full Text] [Related]
20. [Efficiency of a new standard chemotherapy regimen in the treatment of patients with recurrent pulmonary tuberculosis]. Chukanov VI; Komissarova OG; Maishin VIu; Abdullaev RIu; Kononets AS Probl Tuberk Bolezn Legk; 2006; (8):9-13. PubMed ID: 17002050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]